Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.
about
Bench-to-bedside review: Clostridium difficile colitisCommunity-associated Clostridium difficile infection and antibiotics: a meta-analysisThe changing epidemiology of Clostridium difficile infectionsAssessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.The magnitude and duration of Clostridium difficile infection risk associated with antibiotic therapy: a hospital cohort studyMulticenter study of the impact of community-onset Clostridium difficile infection on surveillance for C. difficile infection.Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing.Clostridium difficile Colitis: Reduced Time to Diagnosis in a Community-Based Outpatient Setting Between 1997 and 2004.Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.Hospital Transfer Network Structure as a Risk Factor for Clostridium difficile InfectionEffectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology GroupFrequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden.The management of Clostridium difficile infection: antibiotics, probiotics and other strategies.Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantationProposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic.Antimicrobial stewardship in patients with cancer.Role of doxycycline in Clostridium difficile infection acquisition.The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections.A case-control study of community-associated Clostridium difficile infection.Evaluation of Risk Factors for Clostridium difficile Infection in Hematopoietic Stem Cell Transplant Recipients.The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia.The importance of considering different healthcare settings when estimating the burden of Clostridium difficile.Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancy.The emerging infectious challenge of clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences.Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.Recommendations for surveillance of Clostridium difficile-associated disease.Clostridium difficile: responding to a new threat from an old enemy.Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study.
P2860
Q24644191-5A7C5200-DFFA-40EA-9AFB-3B19A5E0F0D1Q28289675-B5016475-3757-4668-B827-028C43D263E1Q28750385-0131E06C-1119-41F0-8ED9-8A8CDDFCBA0AQ30229124-A97BA816-7104-4781-B3CD-ED2329830811Q34089890-23DADC0E-32E2-49E6-85B6-9DECB0512840Q34141945-2A64A3A3-CE32-4959-AB9C-FE302985A385Q34162226-DA2C73EE-33A8-4094-9474-E92F8B6756BFQ34623024-CD70C3F9-C8F1-4AC0-8942-77CDBE91F668Q34732564-CDD7BFF2-A1DF-4955-B7D6-0658E8DFF286Q36531406-EF5F7D13-9086-43DA-BE73-CB6D5B9E0BB0Q36814599-5404975C-EA83-4114-B0D1-57971A5BB89BQ36853764-603B8506-EA43-45DD-8A7B-C01BCBF75532Q37111226-342E0CB0-2A91-4EAE-84B8-D50E7E68B96DQ37386066-26C8C844-BC17-4EA5-8F02-FFFC2F9660ACQ37697321-9CAA2289-03BB-441C-ACEA-CC8F4CE809BBQ38073198-2629B9E2-42C6-4841-8C54-F26614C4A08CQ38200538-26A2990F-237A-44DF-98CD-33029F3AD73FQ38515096-B3594373-0EA8-459E-B646-085D21DC8681Q39844072-26F61106-C10D-4AE1-9055-3EF270EDB232Q40321852-7C4DA1CE-9137-49B1-8248-8CF47F950767Q41461523-1F9A1D0E-0E70-47BC-A042-8994A39CB84CQ41615881-F4C2271C-A081-436F-BA3F-5EABAD29F0FAQ42279832-343EC710-5834-4CA6-A3BD-1CB2B1B4E0B2Q44537417-521A38E6-4B80-446F-AFE7-218EF2542400Q45332183-61BC65EF-94C3-4F6B-B70B-77A9220C0C1FQ48920404-AC4B92B8-B24A-44D3-B557-483F6B3ADB7AQ55041218-48350D9F-7CDA-4FA6-8083-0555DA6A19A5Q55383075-26FD5537-EDF8-4842-9A9C-B5ED010AB514
P2860
Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Risk factors for acquisition o ...... patients at a cancer hospital.
@ast
Risk factors for acquisition o ...... patients at a cancer hospital.
@en
Risk factors for acquisition o ...... patients at a cancer hospital.
@nl
type
label
Risk factors for acquisition o ...... patients at a cancer hospital.
@ast
Risk factors for acquisition o ...... patients at a cancer hospital.
@en
Risk factors for acquisition o ...... patients at a cancer hospital.
@nl
prefLabel
Risk factors for acquisition o ...... patients at a cancer hospital.
@ast
Risk factors for acquisition o ...... patients at a cancer hospital.
@en
Risk factors for acquisition o ...... patients at a cancer hospital.
@nl
P2093
P2860
P356
P1476
Risk factors for acquisition o ...... patients at a cancer hospital.
@en
P2093
Janet Eagan
Kent A Sepkowitz
SeJean Sohn
Sharp F Malak
Tara N Palmore
P2860
P304
P356
10.1086/502602
P577
2005-08-01T00:00:00Z